GoHealth, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $361.8M | $798.9M | $734.7M | $631.7M | $1.1B |
| Operating income | -$412.9M | -$7.0M | -$81.7M | -$318.7M | -$489.4M |
| Interest expense | $87.3M | $72.9M | $69.5M | $57.1M | $33.5M |
| Pretax income | -$501.1M | -$5.1M | -$151.1M | -$375.6M | -$534.2M |
| Income tax expense | -$3.3M | $2.3M | $154,000 | $764,000 | -$24,000 |
| Net income | -$257.1M | -$2.9M | -$63.3M | -$148.7M | -$189.4M |
| Balance Sheet | |||||
| Cash and equivalents | $32.9M | $40.9M | $90.8M | $16.5M | $84.4M |
| Current assets | $285.8M | $400.4M | $476.4M | $414.6M | $429.0M |
| Total assets | $987.4M | $1.5B | $1.5B | $1.7B | $2.1B |
| Current liabilities | $141.5M | $338.1M | $370.0M | $265.5M | $217.1M |
| Total debt | $688.5M | $505.0M | $502.8M | $518.1M | $678.4M |
| Stockholders' equity | $37.9M | $241.8M | $231.0M | $268.8M | $353.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$121.9M | -$21.6M | $109.1M | $60.9M | -$299.0M |
| Depreciation and amortization | $9.6M | $11.8M | $11.7M | $12.9M | $13.5M |
| Stock-based compensation | $9.2M | $11.3M | $19.5M | $27.1M | $27.3M |
| Capital expenditure | $8.2M | $13.7M | $13.7M | $13.5M | $19.8M |
| Free cash flow | -$130.2M | -$35.3M | $95.4M | $47.4M | -$318.8M |
| Impairments | $260.0M | $0 | $10.0M | $0 | $386.6M |
Shares outstanding 29.3M · Free float 5.9%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.